Viridian Therapeutics Inc (VRDN) Testing Investors’ Patience Right Now
Currently, there are 63.89M common shares owned by the public and among those 55.55M shares have been available to trade. The company’s stock has a 5-day price change of 29.58% and 53.44% over the past three months. VRDN shares are trading -13.91% year to date (YTD), with the 12-month market performance up to 3.14% higher. […]
